JDBRX
Price
$50.37
Change
+$0.16 (+0.32%)
Updated
Oct 17 closing price
Net Assets
28.02B
RLBFX
Price
$39.08
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

JDBRX vs RLBFX

Header iconJDBRX vs RLBFX Comparison
Open Charts JDBRX vs RLBFXBanner chart's image
Janus Henderson Balanced R
Price$50.37
Change+$0.16 (+0.32%)
VolumeN/A
Net Assets28.02B
American Funds American Balanced R5
Price$39.08
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
JDBRX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
JDBRX vs. RLBFX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDBRX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 266B vs. JDBRX (28B). RLBFX pays higher dividends than JDBRX: RLBFX (2.00) vs JDBRX (1.17). JDBRX was incepted earlier than RLBFX: JDBRX (16 years) vs RLBFX (23 years). JDBRX (1.31) is less costly to investors than RLBFX (0.29). JDBRX is a more actively managed with annual turnover of: 76.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than JDBRX: RLBFX (250) vs JDBRX (2500). RLBFX annual gain was more profitable for investors over the last year : 9.05 vs. JDBRX (6.79). RLBFX return over 5 years is better than : 43.90 vs. JDBRX (34.60).
JDBRXRLBFXJDBRX / RLBFX
Total Expense Ratio1.310.29452%
Annual Report Gross Expense Ratio1.310.29452%
Fund Existence16 years23 years-
Gain YTD12.42414.89083%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets28B266B11%
Annual Yield % from dividends1.172.0058%
Returns for 1 year6.799.0575%
Returns for 3 years44.6751.8586%
Returns for 5 years34.6043.9079%
Returns for 10 years88.6078.80112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELAN21.420.90
+4.39%
Elanco Animal Health
PRTC18.000.46
+2.65%
PureTech Health plc
UK1.040.01
+0.97%
Ucommune International Ltd
XBIT2.49N/A
N/A
XBiotech
WLYB36.95-0.41
-1.10%
John Wiley & Sons